Mark Steele

Mark Steele possesses over forty years of experience in the pharmaceutical industry, with a focus on Animal Health Regulatory Affairs, particularly in Chemistry, Manufacturing, and Controls (CMC). Since April 2018, Mark has held the position of Retired CMC Senior Director. Prior to retirement, Mark served as Director of Regulatory Affairs, CMC Pre-Approval at Zoetis, leading a global team and overseeing regulatory strategies for pre and post-approval pharmaceutical products. Previous roles include Senior Director of Regulatory Affairs CMC at Zoetis, Director of Regulatory Affairs for Novartis Animal Health, and various positions at Pfizer Animal Health, where responsibilities spanned New Animal Drug Applications and compliance management. Mark began the career at The Upjohn Company, formulating new animal health products. Mark holds a Bachelor of Business Administration in Management from Western Michigan University's Haworth College of Business.